memantine and kynurenic acid

memantine has been researched along with kynurenic acid in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	2 (28.57)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Herrera, AJ; Osborne, NN	1
Grundke-Iqbal, I; Haque, N; Iqbal, K; Li, L; Sengupta, A	1
Kloc, R; Luchowska, E; Owe-Larsson, B; Urbanska, EM; Wielosz, M	1
Ahn, DK; Bae, YC; Bonfa, E; Park, MK; Woo, YW; Yang, GY	1
Ahn, DK; Bae, YC; Kim, MJ; Lee, JH; Park, MK; Park, YY; Won, KA; Yang, GY	1
Majláth, Z; Toldi, J; Török, N; Vécsei, L	1
Koola, MM	1

Reviews

2 review(s) available for memantine and kynurenic acid

Article	Year
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects. Current neuropharmacology, 2016, Volume: 14, Issue:2 Topics: Alzheimer Disease; Animals; Brain; Excitatory Amino Acid Antagonists; Humans; Kynurenic Acid; Memantine; Receptors, N-Methyl-D-Aspartate; Synapses	2016
Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target Engagement. The primary care companion for CNS disorders, 2018, Mar-01, Volume: 20, Issue:2 Topics: Animals; Cognitive Dysfunction; Drug Therapy, Combination; Electroconvulsive Therapy; Galantamine; Humans; Kynurenic Acid; Memantine; Mental Disorders; Nervous System Diseases; Nootropic Agents	2018

Article

Year

Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.

Current neuropharmacology, 2016, Volume: 14, Issue:2

Topics: Alzheimer Disease; Animals; Brain; Excitatory Amino Acid Antagonists; Humans; Kynurenic Acid; Memantine; Receptors, N-Methyl-D-Aspartate; Synapses

2016

Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target Engagement.

The primary care companion for CNS disorders, 2018, Mar-01, Volume: 20, Issue:2

Topics: Animals; Cognitive Dysfunction; Drug Therapy, Combination; Electroconvulsive Therapy; Galantamine; Humans; Kynurenic Acid; Memantine; Mental Disorders; Nervous System Diseases; Nootropic Agents

2018

Other Studies

5 other study(ies) available for memantine and kynurenic acid

Article	Year
The effect of experimental ischaemia and excitatory amino acid agonists on the GABA and serotonin immunoreactivities in the rabbit retina. Neuroscience, 1994, Volume: 59, Issue:4 Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Aminobutyrates; Animals; Cycloleucine; Dextromethorphan; Eye Proteins; gamma-Aminobutyric Acid; Glucose; Glutamates; Glutamic Acid; Intraocular Pressure; Ischemia; Kainic Acid; Kynurenic Acid; Memantine; N-Methylaspartate; Oxygen; Potassium Cyanide; Quinoxalines; Rabbits; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Retina; Retinal Vessels; Serotonin	1994
Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration. FEBS letters, 2004, May-21, Volume: 566, Issue:1-3 Topics: 2-Amino-5-phosphonovalerate; Alzheimer Disease; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Kynurenic Acid; Memantine; Microtubule-Associated Proteins; Nerve Degeneration; Neurofibrils; Neuroprotective Agents; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Rats; Rats, Wistar; tau Proteins	2004
Memantine increases brain production of kynurenic acid via protein kinase A-dependent mechanism. Neuroscience letters, 2008, Apr-18, Volume: 435, Issue:2 Topics: Analysis of Variance; Animals; Animals, Newborn; Brain; Carbazoles; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclic AMP-Dependent Protein Kinases; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; In Vitro Techniques; Isoquinolines; Kynurenic Acid; Male; Memantine; Neurons; Piperidines; Pyrroles; Rats; Rats, Wistar	2008
Intracisternal administration of NR2 antagonists attenuates facial formalin-induced nociceptive behavior in rats. Journal of orofacial pain, 2010,Spring, Volume: 24, Issue:2 Topics: Animals; Behavior, Animal; Cisterna Magna; Disease Models, Animal; Excitatory Amino Acid Antagonists; Facial Pain; Formaldehyde; Injections; Injections, Subcutaneous; Kynurenic Acid; Male; Memantine; Motor Activity; Nociceptors; Phenols; Piperazines; Piperidines; Pruritus; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Time Factors; Vibrissae	2010
Peripheral administration of NR2 antagonists attenuates orofacial formalin-induced nociceptive behavior in rats. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jun-01, Volume: 35, Issue:4 Topics: Animals; Behavior, Animal; Excitatory Amino Acid Antagonists; Facial Pain; Injections; Kynurenic Acid; Male; Memantine; Pain Measurement; Phenols; Piperidines; Postural Balance; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Vibrissae	2011